Le Lézard
Classified in: Science and technology, Business
Subjects: PDT, ACC

Finom Raises Midterm $37 mln on First Complex Blockchain-Based Platform With AI-Advising


TEUFEN, Switzerland, December 18, 2017 /PRNewswire/ --

Up to date, financial blockchain corporation Finom AG raised $37 million of $101 declared during tokenized equity offering. The project releases both a security FIN and utility NOM tokens. FIN token is executed pursuant to Regulation D of the U.S. Securities Act of 1933. Its holders will be able to receive dividends and vote as traditional stockholders do. The token sale closes on December 30, 2017.

     (Photo: http://mma.prnewswire.com/media/619940/Finom_AG_Token_Sale.jpg )

     (Logo: http://mma.prnewswire.com/media/619911/Finom_AG_Logo.jpg )

Finom makes the world of finance available to everyone by providing a blockchain ecosystem with a single point of entry and AI-assistant. It will help the system adapt to user's goals and offer relevant solutions.

FIN token is a digital equivalent of Finom's shares. When purchasing security tokens, each investor gets utility as a bonus in 1:1 proportion. NOM tokens are expected to be listed on cryptocurrency exchanges after the token sale. The NOM token gives commission discounts, along with special privileges attached to using Finom bank cards and Finom advertising system.

The Finom ecosystem will eventually take care of all financial operations including banking integration, payments processing, factoring. Finom plans to introduce cryptocurrency wallets with linked debit cards, launch a cryptocurrency bank with a network of terminals by 2020.

Finom is a financial blockchain corporation grown out of five companies: Nanopool, TabTrader, Cryptonit, Cryptal, Beetle.io. Services already reach 520,000 users.

 

Disclaimer: 

This press release contains statements which, to the extent that they don't recite historical facts, constitute forward-looking statements. These statements can be identified by the fact that they don't relate strictly to historical or current facts and may include the words "may," "will," "expect," "plan" or other words or expressions of similar meaning. These forward-looking statements are based on the current expectations of Finom about future events. Consequently, actual results may differ materially from those that might be anticipated from forward-looking statements. Considering these and other uncertainties, the reader should not regard the inclusion of a forward-looking statement in this press release as a representation by Finom that its plans and objectives will be achieved, and should not place undue reliance on such forward-looking statements. Finom does not undertake any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law. 


Contact: 
Toma Besedina 
PR Manager,
Finom

[email protected]
+79650195246  


These press releases may also interest you

at 10:45
The "PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2023 to 2027" report has been added to...

at 10:45
Fluency, the leading innovator of digital advertising management and automation solutions for agencies and large enterprises, announced today that it earned the number one ranking in the small business category...

at 10:31
Gulfstream Aerospace Corp., a wholly owned subsidiary of General Dynamics , today announced the all-new Gulfstream G700 has received Federal Aviation Administration (FAA) type certification, paving the way for customer deliveries of the most spacious...

at 10:30
The "Licensing Deals in Biotechnology 2019-2024" report has been added to ResearchAndMarkets.com's offering. Licensing Deals in Biotechnology provides a detailed understanding and analysis of how and why companies enter licensing deals. Fully...

at 10:30
The "Molecular Diagnostics for Cancer: Markets Forecasts by Cancer Type, Product, and Place with Executive & Consultant Guides and Customization. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering. Exciting technical...

at 10:30
RIVANNA®, a developer of imaging-based medical solutions, names Craig Loomis as senior director of product management. With over 25 years of extensive experience in global product development and commercialization within the healthcare sector, Mr....



News published on and distributed by: